| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |